P Reichardt

发表

RICHTUNGSVERHALTEN VON LASTZUEGEN IN DER VOLLBREMSPHASE

P Reichardt, 1981 .

Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.

P Reichardt, J. Blay, G. Demetri, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

P Reichardt, R Gürtler, D. Huhn, 1996, Cancer research.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P Reichardt, I Judson, Robin L. Jones, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.